4.4 Article

A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type 1a and fructose-1,6-bisphosphatase deficiency

Journal

JOURNAL OF INHERITED METABOLIC DISEASE
Volume 33, Issue 1, Pages 25-31

Publisher

SPRINGER
DOI: 10.1007/s10545-009-9030-9

Keywords

-

Ask authors/readers for more resources

A potential role for muscle in glucose homeostasis was recently suggested based on characterization of extrahepatic and extrarenal glucose-6-phosphatase (glucose-6-phosphatase-beta). To study the role of extrahepatic tissue in glucose homeostasis during fasting glucose kinetics were studied in two patients with a deficient hepatic and renal glycogenolysis and/or gluconeogenesis. Endogenous glucose production (EGP), glycogenolysis (GGL), and gluconeogenesis (GNG) were quantified with stable isotopes in a patient with glycogen storage disease type 1a (GSD-1a) and a patient with fructose-1,6-bisphosphatase (FBPase) deficiency. The [6,6-H-2(2)]glucose dilution method in combination with the deuterated water method was used during individualized fasting tests. Both patients became hypoglycemic after 2.5 and 14.5 h fasting, respectively. At that time, the patient with GSD-1a had EGP 3.84 mu mol/kg per min (30% of normal EGP after an overnight fast), GGL 3.09 mu mol/kg per min, and GNG 0.75 mu mol/kg per min. The patient with FBPase deficiency had EGP 8.53 mu mol/kg per min (62% of normal EGP after an overnight fast), GGL 6.89 mu mol/kg per min GGL, and GNG 1.64 mu mol/kg per min. EGP was severely hampered in both patients, resulting in hypoglycemia. However, despite defective hepatic and renal GNG in both disorders and defective hepatic GGL in GSD-1a, both patients were still able to produce glucose via both pathways. As all necessary enzymes of these pathways have now been functionally detected in muscle, a contribution of muscle to EGP during fasting via both GGL as well as GNG is suggested.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Nutrition & Dietetics

Exploring the metabolic fate of medium-chain triglycerides in healthy individuals using a stable isotope tracer

Suzan J. G. Knottnerus, Dewi van Harskamp, Henk Schierbeek, Jeannette C. Bleeker, Loek L. Crefcoeur, Sacha Ferdinandusse, Johannes B. van Goudoever, Riekelt H. Houtkooper, Lodewijk IJlst, Mirjam Langeveld, Ronald J. A. Wanders, Frederic M. Vaz, Frits A. Wijburg, Gepke Visser

Summary: The study investigated the metabolic fates of MCT in healthy individuals using a C-13-labeled MCT tracer. Results showed that when provided as single energy source, 42% of MCT was converted to CO2, while in combination with carbohydrates and proteins in the diet, oxidation of MCT was higher at 62%. Furthermore, less than 1% of C-13-label was incorporated in LCFA in plasma, indicating that administered MCT underwent chain-elongation to LCT.

CLINICAL NUTRITION (2021)

Article Genetics & Heredity

Preconception expanded carrier screening: Impact of information presented by text or video on genetic knowledge and attitudes

Thirsa Conijn, Stephanie C. M. Nijmeijer, Phillis Lakeman, Lidewij Henneman, Frits A. Wijburg, Lotte Haverman

Summary: This study investigated the impact of an educational video compared to an educational text on the knowledge and attitudes toward preconception expanded carrier screening (ECS). Results showed that participants who were offered the video had better genetic knowledge, perceived MPS III as more severe, perceived their risks higher, and were more likely to participate in ECS compared to those who were offered text. Online videos may serve as a valuable tool in genetic counseling, increasing knowledge on ECS and included severe genetic disorders in preconception screening panels.

JOURNAL OF GENETIC COUNSELING (2021)

Article Pharmacology & Pharmacy

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Do not Improve with Carnitine Supplementation

Arie O. Verkerk, Suzan J. G. Knottnerus, Vincent Portero, Jeannette C. Bleeker, Sacha Ferdinandusse, Kaomei Guan, Lodewijk IJlst, Gepke Visser, Ronald J. A. Wanders, Frits A. Wijburg, Connie R. Bezzina, Isabella Mengarelli, Riekelt H. Houtkooper

Summary: Patients with VLCADD show abnormal levels of long-chain acylcarnitines and electrophysiological abnormalities in hiPSC-CMs, which are not normalized by carnitine supplementation. This suggests that carnitine supplementation may not be beneficial against cardiac arrhythmias in VLCADD patients.

FRONTIERS IN PHARMACOLOGY (2021)

Article Endocrinology & Metabolism

Congenital disorders of glycosylation with defective fucosylation

Andreas Huellen, Kristina Falkenstein, Corina Weigel, Hidde Huidekoper, Nora Naumann-Bartsch, Johannes Spenger, Rene G. Feichtinger, Jacqueline Schaefers, Stephanie Frenz, Daniel Kotlarz, Tooba Momen, Razieh Khoshnevisan, Korbinian M. Riedhammer, Rene Santer, Theresia Herget, Alexander Rennings, Dirk J. Lefeber, Johannes A. Mayr, Christian Thiel, Saskia B. Wortmann

Summary: Fucosylation plays a crucial role in cell functions and is associated with various disorders. This review examines the clinical manifestations, genotypes, and treatment approaches of 25 patients with fucosylation-related defects, as well as discusses the efficacy of fucose therapy.

JOURNAL OF INHERITED METABOLIC DISEASE (2021)

Article Pediatrics

Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium

Imke Anise Maartje Ditters, Hidde Harmen Huidekoper, Michelle Elisabeth Kruijshaar, Dimitris Rizopoulos, Andreas Hahn, Tiziana Enrico Mongini, Francois Labarthe, Marine Tardieu, Brigitte Chabrol, Anais Brassier, Rossella Parini, Giancarlo Parenti, Nadine Anna Maria Elisabeth van der Beek, Ans Tjitske van der Ploeg, Johanna Maria Pieternel van den Hout

Summary: This study assessed the effect of enzyme replacement therapy (ERT) with alglucosidase alfa on survival and walking ability in patients with classic infantile Pompe disease. The results showed that a high ERT dosage of 40 mg/kg per week significantly improved survival compared to the standard recommended dosage of 20 mg/kg every other week. These findings suggest a need for reconsideration of the currently registered dosage.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Article Endocrinology & Metabolism

Thermo-sensitive mitochondrial trifunctional protein deficiency presenting with episodic myopathy

Marit Schwantje, Merel S. Ebberink, Mirjam Doolaard, Jos P. N. Ruiter, Sabine A. Fuchs, Niklas Darin, Carola Hedberg-Oldfors, Luc Regal, Laura Donker Kaat, Hidde H. Huidekoper, Simon Olpin, Duncan Cole, Stuart J. Moat, Gepke Visser, Sacha Ferdinandusse

Summary: This study describes five patients with thermo-sensitive MTP deficiency, with onset in childhood and myopathic symptoms triggered by fever or exercise. The absence of characteristic acylcarnitine abnormalities poses a risk for delayed diagnosis, while preventive measures can improve symptoms.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

Article Endocrinology & Metabolism

Integration of metabolomics with genomics: Metabolic gene prioritization using metabolomics data and genomic variant (CADD) scores

Michiel Bongaerts, Ramon Bonte, Serwet Demirdas, Hidde H. Huidekoper, Janneke Langendonk, Martina Wilke, Walter de Valk, Henk J. Blom, Marcel J. T. Reinders, George J. G. Ruijter

Summary: This study presents a computational approach, called Reafect, that integrates metabolomics data and sequencing data to improve the diagnostic process for finding disease-causing genetic variants in patients with inborn errors of metabolism (IEM). The approach takes into account multiple factors and calculates a score for each reaction in a metabolic pathway. The results show that Reafect accurately identifies deficient enzymes and disease-causing genes, and the integration with CADD scores further improves the prioritization of affected genes. Overall, the findings suggest that metabolomics data enhances the identification of affected genes in IEM patients.

MOLECULAR GENETICS AND METABOLISM (2022)

Letter Hematology

Megalobastic anemia, infantile leukemia, and immunodeficiency caused by a novel homozygous mutation in the DHFR gene

Taco W. Kuijpers, Andrica C. H. de Vries, Ester M. van Leeuwen, A. (Ton) A. M. Ermens, Saskia de Pont, Desiree E. C. Smith, Mirjam M. C. Wamelink, Arjen R. Mensenkamp, Marcel R. Nelen, Hana Lango Allen, Steven T. Pals, Berna H. B. Beverloo, Hidde H. Huidekoper, Anja Wagner

BLOOD ADVANCES (2022)

Article Endocrinology & Metabolism

Multi-omics in classical galactosemia: Evidence for the involvement of multiple metabolic pathways

Merel E. Hermans, Michel van Weeghel, Frederic M. Vaz, Sacha Ferdinandusse, Carla E. M. Hollak, Hidde H. Huidekoper, Mirian C. H. Janssen, Andre B. P. van Kuilenburg, Mia L. Pras-Raves, Mirjam M. C. Wamelink, Ronald J. A. Wanders, Mendy M. Welsink-Karssies, Annet M. Bosch

Summary: Classical galactosemia is a common metabolic disorder that leads to intellectual disability and movement disorders. In this study, metabolomics and lipidomics analysis revealed that the disease affects multiple metabolic pathways and compromises the energy status of cells.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

Article Genetics & Heredity

Effectiveness of time-limited eye movement desensitization reprocessing therapy for parents of children with a rare life-limiting illness: a randomized clinical trial

T. Conijn, C. De Roos, H. J. Vreugdenhil, E. M. Van Dijk-Lokkart, F. A. Wijburg, L. Haverman

Summary: This study evaluated the feasibility and effectiveness of time-limited EMDR therapy in reducing PTSD symptoms, psychological comorbidity, distress, and parenting stress in parents of children with a rare progressive life-limiting illness. The results showed that EMDR significantly reduced PTSD symptom severity, as well as comorbid psychological symptoms, distress, and parenting stress. EMDR was well-tolerated, associated with high therapy adherence, and had no adverse events.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Article Genetics & Heredity

Web-accessible application for identifying pathogenic transcripts with RNA-seq: Increased sensitivity in diagnosis of neurodevelopmental disorders

Jordy Dekker, Rachel Schot, Michiel Bongaerts, Walter G. de Valk, Monique M. van Veghel-Plandsoen, Kathryn Monfils, Hannie Douben, Peter Elfferich, Esmee Kasteleijn, Leontine M. A. van Unen, Geert Geeven, Jasper J. Saris, Yvette van Ierland, Frans W. Verheijen, Marianne L. T. van der Sterre, Farah Sadeghi Niaraki, Daphne J. Smits, Hidde H. Huidekoper, Monique Williams, Martina Wilke, Virginie J. M. Verhoeven, Marieke Joosten, Anneke J. A. Kievit, Ingrid M. B. H. van de Laar, Lies H. Hoefsloot, Marianne Hoogeveen-Westerveld, Mark Nellist, Grazia M. S. Mancini, Tjakko J. van Ham

Summary: The study explores the diagnostic potential of RNA-seq in neurodevelopmental disorders (NDDs) and demonstrates its efficacy in molecular diagnosis. RNA-seq analysis on cultured skin fibroblasts helps identify intragenic deletions, monoallelic expression, and variants impacting transcription. The use of cycloheximide treatment and exonic/intronic Z score analysis improves detection and resolution of aberrant splicing. The study highlights the need for customizing RNA-seq and provides a user-friendly web application for diagnostic purposes.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

Article Medical Laboratory Technology

Newborn screening for Cerebrotendinous Xanthomatosis: A retrospective biomarker study using both flow-injection and UPLC-MS/MS analysis in newborns

Frederic M. Vaz, Youssra Jamal, Rob Barto, Michael H. Gelb, Andrea E. DeBarber, Ron A. Wevers, Marcel R. Nelen, Aad Verrips, Albert H. Bootsma, Marelle J. Bouva, Nick Kleise, Walter van der Zee, Tao He, Gajja S. Salomons, Hidde H. Huidekoper

Summary: This study aims to test the feasibility of newborn screening for Cerebrotendinous Xanthomatosis (CTX). It was found that using FIA-MS/MS or UPLC-MS/MS to measure the metabolite ratios of three CTX biomarkers is feasible for newborn screening.

CLINICA CHIMICA ACTA (2023)

Article Oncology

Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions

Imke A. M. Ditters, Harmke A. A. van Kooten, Nadine A. M. E. van der Beek, Jacqueline F. F. Hardon, Gamida Ismailova, Esther Brusse, Michelle E. E. Kruijshaar, Ans T. T. van der Ploeg, Johanna M. P. van den Hout, Hidde H. H. Huidekoper

Summary: This study provides an overview of the experience with home-based infusions of alglucosidase alfa in adult Pompe patients in the Netherlands. The results demonstrate that home administration of alglucosidase alfa is safe and feasible, with the appropriate infrastructure.

BIODRUGS (2023)

Article Genetics & Heredity

Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study

Imke A. M. Ditters, Nadine A. M. E. van der Beek, Esther Brusse, Ans T. van der Ploeg, Johanna M. P. van den Hout, Hidde H. Huidekoper

Summary: Home-based enzyme replacement therapy (ERT) in Pompe disease has been shown to be safe and effective, with few mild symptoms reported during or after infusion. This patient-centered approach to treatment offers increased flexibility and autonomy for patients.

ORPHANET JOURNAL OF RARE DISEASES (2023)

Review Biochemistry & Molecular Biology

Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review

Imke A. M. Ditters, Harmke A. van Kooten, Nadine A. M. E. van der Beek, Ans T. van der Ploeg, Hidde H. Huidekoper, Johanna M. P. van den Hout

Summary: The impact of high antibody titres on treatment response in adults with late-onset Pompe disease remains unclear, but it may contribute to clinical decline in a minority of patients.

BIOMOLECULES (2023)

No Data Available